Altamira Therapeutics Ltd (CYTO)
1.64
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
1.64
0.00 (0.00%)
After-Hours: 18:18
Altamira Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| June 30, 2023 | -1.678 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.7059 |
| June 30, 2022 | 0.6126 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.678
Minimum
Jun 2023
0.6126
Maximum
Jun 2022
-0.4427
Average
-0.3529
Median
Debt to Equity Ratio Benchmarks
| Kiniksa Pharmaceuticals Ltd | 0.00 |
| Tiziana Life Sciences Ltd | -- |
| Landos Biopharma Inc | -- |
| Masimo Corp | 0.6638 |
| AbbVie Inc | 9.242 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.160M |
| Total Liabilities (Quarterly) | 1.471M |
| Shareholders Equity (Quarterly) | 7.690M |
| Current Ratio | 1.376 |
| Net Debt Paydown Yield | 31.93% |